Haemonetics (HAE) Tops Q2 EPS by 11c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.00 --0%
Revenue Growth %: +2.3%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +2.3%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $209 million versus the consensus estimate of $207.65 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
- WisdomTree reports $8.9B in net inflows for first half of 2026
- B. Riley sees strong demand for Grand Theft Auto VI ahead of launch
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
